Prompted by a flurry of new evidence, two leading cardiology groups have revised their guidelines for the management of acute coronary syndromes just 18 months after the last revision.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

New ACC/AHA guidelines reshape drug therapy for acute coronary syndromes

Newsletter